COVID-19 is Affecting the Presentation and Treatment of Melanoma Patients in the Northeastern United States

[1]  Shimul A. Shah,et al.  Impact of the COVID-19 Pandemic on Lung Cancer Screening Program and Subsequent Lung Cancer , 2020, Journal of the American College of Surgeons.

[2]  E. Feletto,et al.  How has COVID-19 impacted cancer screening? Adaptation of services and the future outlook in Australia. , 2020, Public health research & practice.

[3]  P. Ascierto,et al.  Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists , 2020, Journal for ImmunoTherapy of Cancer.

[4]  R. Mesa,et al.  The Impact of COVID-19 on Cancer Screening: Challenges and Opportunities , 2020, JMIR cancer.

[5]  G. Ferrara,et al.  Cancer Diagnostic Delay in Northern and Central Italy During the 2020 Lockdown Due to the Coronavirus Disease 2019 Pandemic , 2020, American journal of clinical pathology.

[6]  J. Park,et al.  Collateral effects of the coronavirus disease 2019 pandemic on lung cancer diagnosis in Korea , 2020, BMC Cancer.

[7]  A. Ribas,et al.  Disparities in Cancer Prevention in the COVID-19 Era , 2020, Cancer Prevention Research.

[8]  J. Vose.  Delay in Cancer Screening and Diagnosis During the COVID-19 Pandemic: What Is the Cost? , 2020, Oncology.

[9]  G. Fabbrocini,et al.  The reduction in the detection of melanoma during the coronavirus disease 2019 (COVID-19) pandemic in a melanoma center of South Italy , 2020, The Journal of dermatological treatment.

[10]  K. Hughes,et al.  Breast imaging, breast surgery, and cancer genetics in the age of COVID‐19 , 2020, Cancer.

[11]  T. Lotti,et al.  Melanoma and COVID‐19: A narrative review focused on treatment , 2020, Dermatologic therapy.

[12]  E. Riboli,et al.  Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study , 2020, The Lancet Oncology.

[13]  A. Purushotham,et al.  The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study , 2020, The Lancet Oncology.

[14]  J. Schmittdiel,et al.  Endometrial Cancer Detection During the Coronavirus Disease 2019 (COVID-19) Pandemic , 2020, Obstetrics and gynecology.

[15]  J. London,et al.  Effects of the COVID-19 Pandemic on Cancer-Related Patient Encounters. , 2020, JCO clinical cancer informatics.

[16]  I. Zalaudek,et al.  Management of patients with melanoma and non-melanoma skin cancers in the coronavirus disease 2019 era , 2020, Chinese medical journal.

[17]  Christopher J. Miller,et al.  Management of primary skin cancer during a pandemic: Multidisciplinary recommendations , 2020, Cancer.

[18]  M. Gasparri,et al.  Changes in breast cancer management during the Corona Virus Disease 19 pandemic: An international survey of the European Breast Cancer Research Association of Surgical Trialists (EUBREAST) , 2020, The Breast.

[19]  G. Fabbrocini,et al.  Melanoma Screening Days During the Coronavirus Disease 2019 (COVID-19) Pandemic: Strategies to Adopt , 2020, Dermatology and Therapy.

[20]  M. Amit,et al.  Pausing cancer screening during the severe acute respiratory syndrome coronavirus 2pandemic: Should we revisit the recommendations? , 2020, European Journal of Cancer.

[21]  E. Nagore,et al.  Estimated effect of COVID‐19 lockdown on melanoma thickness and prognosis: a rate of growth model , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

[22]  S. Duffy,et al.  Impact of the COVID-19 pandemic on the symptomatic diagnosis of cancer: the view from primary care , 2020, The Lancet Oncology.

[23]  The Lancet Oncology,et al.  Safeguarding cancer care in a post-COVID-19 world , 2020, The Lancet Oncology.

[24]  I. Nagtegaal,et al.  Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands , 2020, The Lancet Oncology.

[25]  M. Handler,et al.  The danger of neglecting melanoma during the COVID-19 pandemic , 2020, The Journal of dermatological treatment.

[26]  Jeffrey E. Lee,et al.  Surgical decision-making and prioritization for cancer patients at the onset of the COVID-19 pandemic: A multidisciplinary approach , 2020, Surgical Oncology.

[27]  A. Halpern,et al.  The first 30 years of the American Academy of Dermatology skin cancer screening program: 1985‐2014 , 2018, Journal of the American Academy of Dermatology.

[28]  Dongliang Wang,et al.  Effect of a delay in definitive surgery in melanoma on overall survival: A NCDB analysis. , 2018 .

[29]  R. Botella-Estrada,et al.  Growth rate as an independent prognostic factor in localized invasive cutaneous melanoma , 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.

[30]  R. Prescott,et al.  Clinical and Laboratory Investigations The time from diagnostic excision biopsy to wide local excision for primary cutaneous malignant melanoma may not affect patient survival , 2002 .

[31]  A. Khorana,et al.  Determination of the impact of melanoma surgical timing on survival using the National Cancer Database , 2018, Journal of the American Academy of Dermatology.